To understand the role of IGF2BP2 in glioma, differential expression analysis was performed based on glioma and normal samples in the TCGA database, which identified a total of 2,281 differentially expressed genes (Figure 1A). This evidence concerns the gene IGF2BP2 and central nervous system cancer.